Orchestra Biomed Holdings Inc (OBIO)
NASDAQ NMS - GLOBAL MARKET · Biotechnology
$3.86+0.04 (+1.05%)Quote refreshed
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Market Cap
$231.1M
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
—
Beta
—
Company overview
No company overview is available for Orchestra Biomed Holdings Inc yet.
Peers in Biotechnology
All in industry →VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%
Recent press releases
Orchestra Biomed Holdings Inc has not issued a press release in this window.
SEC filings
All filings →Orchestra Biomed Holdings Inc has not filed an SEC document in this window.
Insider trades
All insider trades →Orchestra Biomed Holdings Inc has no reported insider trades in the last 90 days.
Institutional holders
All holders →As of 2025-12-31 · prior 2025-09-30
RTW INVESTMENTS, LP$34.5M
8,306,063 sh0.0%
PERCEPTIVE ADVISORS LLC$21.3M
5,127,256 sh-3.1%
VANGUARD GROUP INC$6.7M
1,604,556 sh+8.3%
473,363 sh+22.4%
BlackRock, Inc.$2.6M
630,901 sh-5.0%
683 Capital Management, LLC$846,915
204,076 sh● NEW
1,000,000 sh-26.8%
MARSHALL WACE, LLP$712,476
171,681 sh● NEW
People at Orchestra Biomed Holdings Inc
All people →Quarterly financials
Full financials →Revenue trend
03/25
$868.0K
NI -$18.8M
06/25
$169.0K
NI -$19.4M
09/25
$861.0K
NI -$20.8M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.40
Prior: $-0.50
Revenue sparkline